The association of muscle size, strength and exercise capacity with all‐cause mortality in non‐dialysis‐dependent CKD patients
Clinical Physiology and Functional Imaging · 2020-11 · 40 (6) · 399-406
DOI: 10.1111/cpf.12655 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Physiology and Functional Imaging, online erschienen am 09.08.2020. Verfasst von Emma L Watson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, University of Leicester, Leicester, UK. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health, Kidney Research UK, National Institute for Health Research.
Abstract (Originalsprache)
Background/Objective Patients with chronic kidney disease (CKD) are commonly reported to exhibit skeletal muscle wasting, reduced strength and exercise capacity. Evidence from patients with end‐stage renal disease (ESRD) demonstrates these factors are associated with mortality, but it is unclear whether this relationship exists earlier in the illness. Our objective was to determine whether muscle size, strength or exercise capacity was associated with all‐cause mortality, unscheduled hospital admissions or time to ESRD in patients not requiring dialysis.
Methods
This is a prospective cohort study of 89 patients with CKD stages 3b‐5 not requiring renal replacement therapy with a mean follow‐up period of 3.3 years in which the contribution of predictors of rectus femoris muscle size, muscle strength, exercise capacity to all‐cause mortality rates, progression to ESRD and time to first hospitalization were investigated.
Results
Unadjusted analysis suggested each 1 cm 2 increase in quadriceps muscle size (measured by ultrasonography cross‐sectional area) was associated with a 38% reduced risk for death ( p = .006), and a 10 m improvement on the incremental shuttle walk test was associated with a 3% reduced risk for death ( p = .04). However, this relationship was not present in analysis adjusted for age, gender and eGFR. No association was seen between any factor for the development of ESRD or time to first hospitalization.
Conclusion
These results suggest that in this small cohort, muscle size and exercise capacity are associated with mortality when considered alone, but this relationship was not present in adjusted analyses. Further investigation in a larger patient group is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
- Department of Health Sciences, University of Leicester, Leicester, UK.
- John Walls Renal Unit, University Hospitals of Leicester NHS Trust, Leicester, UK.
- Department of Respiratory Sciences, University of Leicester, Leicester, UK.
ORCID-Profile: Emma L Watson
Förderung
- Department of Health
- Kidney Research UK
- National Institute for Health Research
Zitieren
APA
Watson, E. L., Major, R. W., Wilkinson, T. J., Greening, N. J., Gould, D. W., Barratt, J., & Smith, A. C. (2020). The association of muscle size, strength and exercise capacity with all‐cause mortality in non‐dialysis‐dependent CKD patients. Clinical Physiology and Functional Imaging, 40(6), 399-406. https://doi.org/10.1111/cpf.12655
Vancouver
Watson EL, Major RW, Wilkinson TJ, Greening NJ, Gould DW, Barratt J, et al. The association of muscle size, strength and exercise capacity with all‐cause mortality in non‐dialysis‐dependent CKD patients. Clinical Physiology and Functional Imaging. 2020;40(6):399-406. doi:10.1111/cpf.12655
BibTeX
@article{Watson2020,
author = {Watson, Emma L and Major, Rupert W and Wilkinson, Thomas J and Greening, Neil J and Gould, Douglas W and Barratt, Jonathan and Smith, Alice C},
title = {The association of muscle size, strength and exercise capacity with all‐cause mortality in non‐dialysis‐dependent CKD patients},
journal = {Clinical Physiology and Functional Imaging},
year = {2020},
volume = {40},
number = {6},
pages = {399--406},
doi = {10.1111/cpf.12655}
}
EUVIMED